Product List     API & Intermediate     

Inhibitors

Find
147
related chemicals for you
CAS:960539-70-2
Molecular Formula:C19H27N3O6
960539-70-2; GSK1278863; GSK-1278863; Jesduvroq; GSK 1278863; N-((1,3-Dicyclohexylhexahydro-2,4,6-Trioxopyrimidin-5-yl)Carbonyl)Glycine; (1,3-Dicyclohexyl-2,4,6-Trioxohexahydropyrimidine-5-Carbonyl)Glycine; 2-[(1,3-Dicyclohexyl-2,4,6-Trioxo-1,3-Diazinan-5-yl)Formamido]Acetic acid; Glycine, N-((1,3-Dicyclohexylhexahydro-2,4,6-Trioxo-5-Pyrimidinyl)Carbonyl)-; Duvroq; 2-[(1,3-Dicyclohexyl-2,4,6-Trioxo-1,3-Diazinane-5-Carbonyl)Amino]Acetic acid; N-[(1,3-Dicyclohexylhexahydro-2,4,6-Trioxopyrimidin-5-yl)Carbonyl]Glycine; Duvroq (TN); Daprodustat;(1,3-Dicyclohexyl-2,4,6-Trioxohexahydropyrimidine-5-Carbonyl)Glycine
Brief Introduction
It is an oral hypoxia inducible factor proline hydroxylase (HIFPH) inhibitor used to treat anemia related to chronic kidney disease.
CAS:495399-09-2
Molecular Formula:C25H29NO4S
Lipaglyn; ZYH1; (S)-2-Ethoxy-3-(4-(2-(2-Methyl-5-(4-(Methylthio)Phenyl)-1H-Pyrrol-1-yl)Ethoxy)Phenyl)Propanoic acid; (2S)-2-Ethoxy-3-[4-[2-[2-Methyl-5-(4-Methylsulfanylphenyl)Pyrrol-1-yl]Ethoxy]Phenyl]Propanoic acid; Saroglitazarum; (2S)-2-Ethoxy-3-(4-(2-(2-Methyl-5-(4-(Methylsulfanyl)Phenyl)-1H-Pyrrol-1-yl(Ethoxy)Phenyl)Propanoic acid; (2S)-2-Ethoxy-3-[4-(2-{2-Methyl-5-[4-(Methylthio)Phenyl]-1H-Pyrrol-1-yl}Ethoxy)Phenyl]Propanoic acid; (S)-Alpha-Ethoxy-4-[2-[-Methyl-5-[4-(Methylthio) Phenyl]-1H-Pyrrol-1-yl]Ethoxy]Benzene-Propanoic acid; Benzenepropanoic ACID, .Alpha.-Ethoxy-4-(2-(2-Methyl-5-(4-(Methylthio)Phenyl)-1H-Pyrrol-1-YL)Ethoxy)-, (.Alpha.S)-
Brief Introduction
It is a drug for the treatment of type 2 diabetes mellitus and dyslipidemia. It is approved for use in India by the Drug Controller General of India. Saroglitazar is indicated for the treatment of diabetic dyslipidemia and hypertriglyceridemia with type 2 diabetes mellitus not controlled by statin therapy.
CAS:1338225-97-0
Molecular Formula:C17H11ClF3N5O3
MK-1439; Pifeltro; Doravirine (MK-1439); 3-Chloro-5-((1-((4-Methyl-5-oxo-4,5-Dihydro-1H-1,2,4-Triazol-3-yl)Methyl)-2-oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-yl)oxy)Benzonitrile; 3-Chloro-5-[1-[(4-Methyl-5-oxo-1H-1,2,4-Triazol-3-yl)Methyl]-2-oxo-4-(Trifluoromethyl)Pyridin-3-yl]Oxybenzonitrile; MK1439; Mk-1439a; 3-Chloro-5-({1-[(4-Methyl-5-Oxo-4,5-Dihydro-1h-1,2,4-Triazol-3-Yl)Methyl]-2-Oxo-4-(Trifluoromethyl)-1,2-Dihydropyridin-3-Yl}oxy)Benzonitrile; Benzonitrile, 3-Chloro-5-((1-((4,5-Dihydro-4-Methyl-5-oxo-1H-1,2,4-Triazol-3-yl)Methyl)-1,2-Dihydro-2-oxo-4-(Trifluoromethyl)-3-Pyridinyl)oxy)-; 4ncg; Pifeltro (TN); 2KW; MK 1439; MK-1439(Doravirine); D0R0TS; Delstrigo Component Doravirine; Doravirine Component OF Delstrigo; 3-Chloro-5-[[1-[(4-Methyl-5-oxo-1H-1,2,4-Triazol-3-yl)Methyl]-2-oxo-4-(Trifluoromethyl)-3-Pyridyl]oxy]Benzonitrile
Brief Introduction
It is a new non nucleoside HIV-1 Reverse-transcriptase inhibitor
CAS:1609392-27-9
Molecular Formula:C20H19D3N8O3
BMS-986165; Tyk2-IN-4; Sotyktu; 6-(Cyclopropanecarboxamido)-4-((2-Methoxy-3-(1-Methyl-1H-1,2,4-Triazol-3-yl)Phenyl)Amino)-N-(Methyl-d3)Pyridazine-3-Carboxamide; Deucravacitinib (BMS-986165)
Brief Introduction
Deucravacitinib is a Tyrosine Kinase 2 Inhibitor. The mechanism of action of deucravacitinib is as a Tyrosine Kinase 2 Inhibitor.
CAS:1420477-60-6
Molecular Formula:C26H23N7O2
Calquence; Acalabrutiib; (S)-4-(8-Amino-3-(1-(but-2-Ynoyl)Pyrrolidin-2-yl)Imidazo[1,5-a]Pyrazin-1-yl)-N-(Pyridin-2-yl)Benzamide
Brief Introduction
Acalabrutinib is an experimental anti-cancer drug and a selective inhibitor of Bruton tyrosine kinase (BTK).
Inquiry ( 
10
 
/ 10
 )
Clear All
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >